Subscribe for the newsletter
Sign in
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Series
Market Research
Thought Leaders
More
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
CMC
Sort By
Newest First
1 / 3
1 / 3
AAV
Overcoming Variability and Scaling Challenges in AAV Manufacturing
Rafal Garus
Viralgen Vector Core
PAO-08-24-CL-03
July 22, 2024
Training
Biotech Training is a Challenge
April Stanley, MS MBA; Koey Keylon
PAO-06-24-NI-01
June 11, 2024
Leap-In Transposase
Leveraging Innovative Transposase Technology for a Highly Reliable and Productive CMC Platform
Wheeler Bio
PAO-06-24-CL-05
May 30, 2024
The PHASE Platform
How Synergistic Collaborations Between Outsourcing Partners Can Accelerate Clinical Success
Wheeler Bio
PAO-05-24-CL-01
May 08, 2024
Advanceability
Right from the Start: Designing Advanceable Formulations and Processes at Phase I
Serán Bioscience
PAO-02-24-CL-09
February 26, 2024
CMC
Revolutionizing Early-Stage Biopharma Development: Introducing Wheeler Bio's Portable CMC® Platform
Wheeler Bio
PAO-12-23-CL-04
February 08, 2024
Drug Development
Podcast: Insights from CDO Experts from Samsung Biologics
Jiyeon Lee; Hyelyoung Jang
Samsung Biologics
POD-01-24-CL-01
January 16, 2024
Glycosylation
S-Glyn™ : Optimizing N-Glycan Profiles and their Effector Functions Using a Design-of-Experiments Approach
Junyong Park
Samsung Biologics
PAO-12-23-CL-06
December 14, 2023
Stem Cell Therapy
Designing A Recipe for Stem Cell Therapy Success
Ben Josey, Ph.D.; Robert Padilla
Corning Life Sciences
PTV-12-23-CL-01
December 12, 2023
Cell and Gene Therapy
Scaling Cell and Gene Therapy Processes from R&D to Production
Shawn Bates; Antonio Fernandez-Perez, Ph.D.
Corning Life Sciences
PAO-12-23-CL-03
December 12, 2023
Cell Culture Media
Market Trends Driving the Embrace of Plant-Based Cell-Culture Media Ingredients
Chris Wiedel
Nu-Tek BioSciences
PAO-10-23-CL-01
December 06, 2023
Cell Culture Media
Enabling Controlled End-to-End Biomanufacturing with Animal-Free Culture Media Products
Thomas Yezzi
Nu-Tek BioSciences
PAO-08-23-CL-05
November 14, 2023
Alloy Therapeutics and Wheeler Bio Announce Preferred Service Offering for Alloy Partners to Accelerate the Translation from Discovery to CMC
Wheeler Bio
PR-M11-23-01
November 08, 2023
Strategic Partnership
Samsung Biologics and Kurma Partners Announce Strategic Partnership for Development and Manufacturing of Biologics for Kurma’s Portfolio Companies
Samsung Biologics
PR-M10-23-06
October 24, 2023
Wheeler Bio Announces Grand Opening of Biomanufacturing Facility
Wheeler Bio
PR-M10-23-01
October 05, 2023
3D Cell Culture
Unleashing the Power of 3D Cell Culture: Revolutionizing Research, Drug Discovery, and Biomedicine
Elizabeth Abraham, Ph.D.; Catherine Siler, Ph.D.
Corning Life Sciences
PAO-09-23-CL-02
September 29, 2023
CMC
The Biopharma Industry is Well Prepared for an Overhaul of the Lead-to-Clinic CMC Process for Antibodies
Jesse McCool, Ph.D.; David Schmidt, M.B.A., M.Sc.; Oren Beske, Ph.D.; Stephen Monks, Ph.D.
Wheeler Bio
PAO-07-23-CL-05
July 26, 2023
Leadership
Wheeler Bio Appoints Dr. Stewart McNaull as Chief Business Officer
Wheeler Bio
PR-M06-23-02
June 06, 2023
History of Innovation
100 Years Young: How Science, Collaboration, and Innovation are Driving Corning’s Future
John Yoshi Shyu, Ph.D.; John M. Tobin IV
Corning Life Sciences
PAO-05-23-CL-08
May 30, 2023
Consulting
Supporting Drug Development – Increasing Probability of Success
Nick Davies; Beth Lindsey; Ian Smart
Verta Life Sciences
PAO-03-23-CL-04
March 24, 2023
